top of page
iPharmaCenter
ipharmacenter Consulting services
ipharmacenter
Consulting services
ipharmacenter
Consulting services
ipharmacenter
Consulting services
Home
Pharma
US FDA Approvals
North America
China Drug Approvals
Japan Drug Approvals | Healthcare
India Drug Approvals
APAC - Drug Approvals
LACAM
Europe
Canada Drug Healthcare News
Brazil - Drug approvals
EMA News
APAC
Therapy News
Immunology
Neurology
Oncology
Kidney Diseases
Cardiovascular
Infections_Vaccines
Metabolic Diseases
Women Health
Healthcare News
US Healthcare News
US Payer News
Europe Healthcare News
NICE Assessment Outcomes
G-BA Assessment Outcomes
APAC - Healthcare News
Lacam Healthcare News
Healthcare Policies
Conferences
All News
For sponsored articles, link insertions, and advertisements, please write to
info@ipharmacenter.com
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
APAC Drug approvals
US_PayerNews
Australia TGA Approvals
Biosimilars
Radioligand therapy
Chikungunya News
NICE recommendations
G-BA Assessment Outcomes
HAS Assessment Outcomes
Neurology
Immunology
Search
Tevimbra Receives U.S. Approval for First-Line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy | iPharmaCenter
BeiGene has announced that the U.S. Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab), in combination with...
ipharmaservices
Mar 5
2025 AAAAI / WAO Joint Congress | American Academy of Allergy, Asthma & Immunology | iPharmaCenter
Depemokimab Demonstrates Clinically Significant Benefits for Chronic Rhinosinusitis Patients with Nasal Polyps (CRSwNP)Phase III ANCHOR-1...
ipharmaservices
Mar 5
bottom of page
